Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy.
Smith DR, Lim ST, Murphy SJX, Hickey FB, Offiah C, Murphy SM, Collins DR, Coughlan T, O'Neill D, Egan B, O'Donnell JS, O'Sullivan JM, McCabe DJH. Smith DR, et al. Among authors: collins dr. J Neurol Sci. 2024 Aug 15;463:123118. doi: 10.1016/j.jns.2024.123118. Epub 2024 Jul 2. J Neurol Sci. 2024. PMID: 39024743 Free article.
Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke.
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Coughlan T, Collins DR, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Tobin WO, et al. Among authors: collins dr. J Neurol. 2014 Jul;261(7):1405-12. doi: 10.1007/s00415-014-7362-3. Epub 2014 Apr 30. J Neurol. 2014. PMID: 24781842
Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy S, Lim SJ, Murphy RP, McCabe D. Tobin WO, et al. Among authors: collins dr. J Neurol Sci. 2017 Apr 15;375:404-410. doi: 10.1016/j.jns.2017.02.045. Epub 2017 Feb 24. J Neurol Sci. 2017. PMID: 28320178
von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli.
Murphy SJX, Lim ST, Hickey F, Kinsella JA, Smith DR, Tierney S, Egan B, Feeley TM, Murphy SM, Collins DR, Coughlan T, O'Neill D, Harbison JA, Madhavan P, O'Neill SM, Colgan MP, O'Donnell JS, O'Sullivan JM, Hamilton G, McCabe DJH. Murphy SJX, et al. Among authors: collins dr. Thromb Haemost. 2021 Jan;121(1):86-97. doi: 10.1055/s-0040-1715440. Epub 2020 Sep 15. Thromb Haemost. 2021. PMID: 32932544 Free PMC article.
Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phases after TIA and ischaemic stroke.
Lim ST, Murphy SJX, Murphy SM, Coughlan T, O'Neill D, Tierney S, Egan B, Collins DR, McCarthy AJ, Lim SY, Smith DR, Cox D, McCabe DJH. Lim ST, et al. Among authors: collins dr. J Neurol Sci. 2022 Oct 15;441:120334. doi: 10.1016/j.jns.2022.120334. Epub 2022 Jul 11. J Neurol Sci. 2022. PMID: 36030623 Free article.
Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO, Kinsella JA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Tobin WO, et al. Among authors: collins dr. Br J Haematol. 2011 Mar;152(5):640-7. doi: 10.1111/j.1365-2141.2010.08539.x. Epub 2011 Jan 12. Br J Haematol. 2011. PMID: 21223254 Free article. Clinical Trial.
High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study.
Tobin WO, Kinsella JA, Coughlan T, Collins DR, O'Neill D, Murphy RP, Egan B, Tierney S, Feeley TM, McCabe DJ. Tobin WO, et al. Among authors: collins dr. Eur J Neurol. 2013 Feb;20(2):344-52. doi: 10.1111/j.1468-1331.2012.03861.x. Epub 2012 Sep 20. Eur J Neurol. 2013. PMID: 22994699 Clinical Trial.
Relationship between 'on-treatment platelet reactivity', shear stress, and micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Murphy SJX, Lim ST, Kinsella JA, Tierney S, Egan B, Feeley TM, Murphy SM, Walsh RA, Collins DR, Coughlan T, O'Neill D, Harbison JA, Madhavan P, O'Neill SM, Colgan MP, Cox D, Moran N, Hamilton G, Meaney JF, McCabe DJH. Murphy SJX, et al. Among authors: collins dr. J Neurol. 2020 Jan;267(1):168-184. doi: 10.1007/s00415-019-09550-3. Epub 2019 Oct 12. J Neurol. 2020. PMID: 31606758
159 results